IBM (IBM) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks.com users have recently been watching Super Micro (SMCI) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Ohtuvayre's robust launch for COPD treatment exceeded expectations, with Q4 revenue of $36.6 million and FY24 revenue of $42.3 million, indicating strong market demand. Verona's financial health is solid with $399.757 million in cash, providing a cash runway into 2028, despite a net loss of $33.8 million in Q4. Verona is extending Ohtuvayre's life cycle through new formulations and fixed-dose combinations, aiming for cash flow break-even with a quarterly run rate near $300 million.

Snowflake (SNOW) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Guidewire's newest launch, Mammoth, is set to empower insurers with speed, agility and smart decision-making.

ITRI and Norgesnett will unveil the Nordics' first grid edge computing project, using smart meters and DI to boost energy efficiency and sustainability.

Crocs (CROX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

REG to gain from premium portfolio of grocery-anchored shopping centers, strategic buyouts and a solid balance sheet. Growing e-commerce adoption is a concern.

CMS keeps out LLY and NVO's obesity drugs from Medicare coverage. Medicare, at present, does not cover obesity drugs if they are solely prescribed for weight loss.

ADP stock is benefiting from a strong customer base and expanding international operations driven by acquisitions.

Beyond analysts' top -and-bottom-line estimates for Lovesac (LOVE), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended January 2025.

Get a deeper insight into the potential performance of CarMax (KMX) for the quarter ended February 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Journey Medical (DERM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Costco's stellar run may not be over, but investors must weigh its premium price against long-term growth potential.

FCPT announces the acquisition of the tenth Burger King property through a sale-leaseback from Ampler Restaurant Group in March.

It's safe to bet on utility stocks like AVA, CMS, EXC and SWX during times of market volatility.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?